215 related articles for article (PubMed ID: 14690017)
1. Clofibrate, a peroxisome-proliferator, enhances reverse cholesterol transport through cytochrome P450 activation and oxysterol generation.
Guan JZ; Tamasawa N; Murakami H; Matsui J; Yamato K; Suda T
Tohoku J Exp Med; 2003 Dec; 201(4):251-9. PubMed ID: 14690017
[TBL] [Abstract][Full Text] [Related]
2. The inhibition of the human cholesterol 7alpha-hydroxylase gene (CYP7A1) promoter by fibrates in cultured cells is mediated via the liver x receptor alpha and peroxisome proliferator-activated receptor alpha heterodimer.
Gbaguidi GF; Agellon LB
Nucleic Acids Res; 2004; 32(3):1113-21. PubMed ID: 14960721
[TBL] [Abstract][Full Text] [Related]
3. PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway.
Ruan XZ; Moorhead JF; Fernando R; Wheeler DC; Powis SH; Varghese Z
J Am Soc Nephrol; 2003 Mar; 14(3):593-600. PubMed ID: 12595494
[TBL] [Abstract][Full Text] [Related]
4. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
[TBL] [Abstract][Full Text] [Related]
5. Specific gene expression of ATP-binding cassette transporters and nuclear hormone receptors in rat liver parenchymal, endothelial, and Kupffer cells.
Hoekstra M; Kruijt JK; Van Eck M; Van Berkel TJ
J Biol Chem; 2003 Jul; 278(28):25448-53. PubMed ID: 12704191
[TBL] [Abstract][Full Text] [Related]
6. Propofol up-regulates expression of ABCA1, ABCG1, and SR-B1 through the PPARγ/LXRα signaling pathway in THP-1 macrophage-derived foam cells.
Ma X; Li SF; Qin ZS; Ye J; Zhao ZL; Fang HH; Yao ZW; Gu MN; Hu YW
Cardiovasc Pathol; 2015; 24(4):230-5. PubMed ID: 25600616
[TBL] [Abstract][Full Text] [Related]
7. FXR-mediated down-regulation of CYP7A1 dominates LXRalpha in long-term cholesterol-fed NZW rabbits.
Xu G; Li H; Pan LX; Shang Q; Honda A; Ananthanarayanan M; Erickson SK; Shneider BL; Shefer S; Bollineni J; Forman BM; Matsuzaki Y; Suchy FJ; Tint GS; Salen G
J Lipid Res; 2003 Oct; 44(10):1956-62. PubMed ID: 12897188
[TBL] [Abstract][Full Text] [Related]
8. Pravastatin activates the expression of farnesoid X receptor and liver X receptor alpha in Hep3B cells.
Byun HW; Hong EM; Park SH; Koh DH; Choi MH; Jang HJ; Kae SH; Lee J
Hepatobiliary Pancreat Dis Int; 2014 Feb; 13(1):65-73. PubMed ID: 24463082
[TBL] [Abstract][Full Text] [Related]
9. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins.
Wang N; Lan D; Chen W; Matsuura F; Tall AR
Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9774-9. PubMed ID: 15210959
[TBL] [Abstract][Full Text] [Related]
10. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions.
Marleau S; Harb D; Bujold K; Avallone R; Iken K; Wang Y; Demers A; Sirois MG; Febbraio M; Silverstein RL; Tremblay A; Ong H
FASEB J; 2005 Nov; 19(13):1869-71. PubMed ID: 16123174
[TBL] [Abstract][Full Text] [Related]
11. Physical and functional interactions between liver X receptor/retinoid X receptor and Sp1 modulate the transcriptional induction of the human ATP binding cassette transporter A1 gene by oxysterols and retinoids.
Thymiakou E; Zannis VI; Kardassis D
Biochemistry; 2007 Oct; 46(41):11473-83. PubMed ID: 17887732
[TBL] [Abstract][Full Text] [Related]
12. Quercetin up-regulates expressions of peroxisome proliferator-activated receptor γ, liver X receptor α, and ATP binding cassette transporter A1 genes and increases cholesterol efflux in human macrophage cell line.
Lee SM; Moon J; Cho Y; Chung JH; Shin MJ
Nutr Res; 2013 Feb; 33(2):136-43. PubMed ID: 23399664
[TBL] [Abstract][Full Text] [Related]
13. Chronic contamination with 137cesium in rat: effect on liver cholesterol metabolism.
Souidi M; Tissandie E; Grandcolas L; Grison S; Paquet F; Voisin P; Aigueperse J; Gourmelon P; Guéguen Y
Int J Toxicol; 2006; 25(6):493-7. PubMed ID: 17132608
[TBL] [Abstract][Full Text] [Related]
14. A novel liver X receptor agonist establishes species differences in the regulation of cholesterol 7alpha-hydroxylase (CYP7a).
Menke JG; Macnaul KL; Hayes NS; Baffic J; Chao YS; Elbrecht A; Kelly LJ; Lam MH; Schmidt A; Sahoo S; Wang J; Wright SD; Xin P; Zhou G; Moller DE; Sparrow CP
Endocrinology; 2002 Jul; 143(7):2548-58. PubMed ID: 12072387
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450--physiological key factor against cholesterol accumulation and the atherosclerotic vascular process.
Luoma PV
Ann Med; 2007; 39(5):359-70. PubMed ID: 17701478
[TBL] [Abstract][Full Text] [Related]
16. Expression of hepatic UDP-glucuronosyltransferase 1A1 and 1A6 correlated with increased expression of the nuclear constitutive androstane receptor and peroxisome proliferator-activated receptor alpha in male rats fed a high-fat and high-sucrose diet.
Osabe M; Sugatani J; Fukuyama T; Ikushiro S; Ikari A; Miwa M
Drug Metab Dispos; 2008 Feb; 36(2):294-302. PubMed ID: 17967931
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor alpha (PPARalpha) and agonist inhibit cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription.
Marrapodi M; Chiang JY
J Lipid Res; 2000 Apr; 41(4):514-20. PubMed ID: 10744771
[TBL] [Abstract][Full Text] [Related]
18. Downregulated CD36 and oxLDL uptake and stimulated ABCA1/G1 and cholesterol efflux as anti-atherosclerotic mechanisms of interleukin-10.
Rubic T; Lorenz RL
Cardiovasc Res; 2006 Feb; 69(2):527-35. PubMed ID: 16336952
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D Protects Against Atherosclerosis via Regulation of Cholesterol Efflux and Macrophage Polarization in Hypercholesterolemic Swine.
Yin K; You Y; Swier V; Tang L; Radwan MM; Pandya AN; Agrawal DK
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2432-42. PubMed ID: 26381871
[TBL] [Abstract][Full Text] [Related]
20. Ligand-induced expression of peroxisome proliferator-activated receptor alpha and activation of fatty acid oxidation enzymes in fatty liver.
Akbiyik F; Cinar K; Demirpence E; Ozsullu T; Tunca R; Haziroglu R; Yurdaydin C; Uzunalimoglu O; Bozkaya H
Eur J Clin Invest; 2004 Jun; 34(6):429-35. PubMed ID: 15200495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
